|
KMID : 1011920140150040027
|
|
International Journal of Arrhythmia
2014 Volume.15 No. 4 p.27 ~ p.34
|
|
|
|
|
Oh Se-Il
|
|
|
Abstract
|
|
|
|
Update interval of guideline publish for atrial fibrillation (AF) is getting shorter than the past due to rapidly expanding knowledge and evidences on AF. According to the current guidelines, catheter ablation is recommended as an alternative to antiarrhythmic drugs for patients with symptomatic recurrent paroxysmal AF, provided the procedure is performed by an experienced center/operator. Catheter ablation is reasonable as firstline therapy in selected patients with paroxysmal AF and no structural heart disease. Continuation of warfarin can be considered throughout the ablation procedure but robust data for NOACs are lacking. Ongoing clinical trials should provide new information for assessing whether catheter ablation is superior to pharmacological therapy for reducing total mortality. These will help us to address whether catheter ablation provides benefit beyond quality of life.
|
|
|
KEYWORD
|
|
|
catheter ablation, atrial fibrillation, guideline
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
|
|